Publications

Below is a list of publications that have directly resulted from, or use data from, POI research.  Links to the article’s abstract in the US National Library of Medicine are provided when available.

  1. Belinson JL, Qiao YL, Pretorius R, Zhang W, et al.:  Prevalence of Cervical Cancer and Feasibility of Screening in Rural China:  A Pilot Study for the ShanxiProvince Cervical Cancer Screening Study.  Int. J Gynecol Cancer 9:411-417, 1999.
  2. Yang L, Zhang WH, Pan QJ, Li L, Rong SD, Belinson JL, Pretorius RG, Qiao YL.  A pilot study for cervical cancer screening trials in Shanxi Province. Bulletin of Chinese Cancer 2000;9(9): 391-392 (Article in Chinese).
  3. Yang L, Qiao YL, Li N, Zhang X, Kong, LH, Rong SD, Ma JF, Belinson J. Synthesis and cluster analysis for multiple screening techniques for cervical cancer. Cancer Research on Prevention and Treatment 2001;28(4):253-255 (Article in Chinese).
  4. Zhao FH, Li N, Ma JF, Zhang X, Wu LY, Rong SD, Lorincz A, Belinson JL, Qiao YL. Study of the association between human papillomavirus infection and cervical cancer in Xiangyuan County, Shanxi Province. Chin J Epidemiol., October 2001; 22(5):375-378 (Article in Chinese).
  5. Belinson JL, Qiao YL, Pretorius RG, Zhang WH et al:  Shanxi Province Cervical Cancer Screening Study.  A Cross-Sectional Comparative Trial of Multiple Techniques to Detect Cervical Intraepithelial Neoplasia.  Gynecol Oncol 83: 439-44, Nov 2001.
  6. Belinson JL, Qiao YL, Pretorius RG, Zhang WH et al: Cervical  Cancer Screening by Simple Visual Inspection after Acetic Acid. Obstetrics and Gynecology 2001; 98:(3),441-444.
  7. Pretorius RG, Belinson JL, Qiao YL, Burchette RJ, Elson P, Zhang WH. Is Colposcopic Impression Influenced by the Colposcopist’s Knowledge of the Result of the Referral Papanicolaou Smear?  J. Repro. Med. 46(8): 724-8, Aug 2001.
  8. Belinson JL,Pan QJ, Biscotti C, Pretorius RG,Elson P, Qiao YL. Primary Screening with Liquid Based Cytology in an Unscreened Population in Rural China, with an Emphasis on Reproducing Unsatisfactory Samples. Acta Cytol. 2002 May-Jun;46(3):470-4.
  9. Rong SD, Chen W, Wu LY, Zhang X, Shen GH, Liu YY, Zhao FH, Ma JF, Qiao YL. Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province. Chinese Journal of Preventive Medicine 2002:36(1):41-43(Article in Chinese).
  10. Pan QJ, Kong LH, Shen GH, Li L, Qiao YL, Zhang WH. Liquid-based cytologic screening compared with HPV testing to detect cervical cancer. Cancer Research on Prevention and Treatment 2002;29(4):303-305 (Article in Chinese).
  11. Tisci  SE, Shen YH, Fife D, Goycoolea JM, Ma CP, Qiao YL, Belinson JL, Huang RD, Qiao YL.Patient acceptance of self-sampling for human papillomavirus in rural china.  J Lower Genital Tract Dis. 2003; 7(2): 107-116.
  12. Shen YH, Chen F, Huang MN, Liu B, Zhao FH, Li SM, Li N, Zhang WH, Rong SD, Wu LY, Ren SD, Huang RD, Qiao YL. Population-based study of HPV infection in high-risk area for cervical cancer in Shanxi Province, China. Acta Acad Med Sin, 2003.25(4): 381-5. (Article in Chinese).
  13. Pan QJ, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong SD, Sun YT. A Thin-Layer Liquid-Based Pap Test for Mass Screening in an Area of China with a High Incidence of Cervical Carcinoma: A Cross-Sectional Comparative Study. ACTA Cytol. 2003; 47:45-50.
  14. Wu LY, Li N, Zhang WH, Li L, Pan QJ, Qiao YL, Rong SD, Zhao FH, Pretorius RG, Belinson JL.  Value of acetic acid smear test for cervical cancer screening.  Ai Zheng. 2003 Oct; 22(10):  1096-8.  Chinese.
  15. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, Li L, Fife D. Shanxi Province Cervical Cancer Screening Study II: Self-Sampling for High-Risk Human Papillomavirus Compared to Direct Sampling for HPV and Liquid Based Cervical Cytology. Int. J. Gyn Cancer 2003; 13:1-8.
  16. Escobar PF, Belinson JL, White A, Shakhova N, Feldchtein F, Kareta M, Gladkova N. Diagnostic Efficacy of Optical Coherence Tomography in the Management of Pre-Invasive and Invasive Cancer of the Uterine Cervix and Vulva.  Int. J. Gyn Cancer.  2004-May-Jun; 14(3):470-4.
  17. Li N, Zhang WH, Wu LY, Li AL, Qiao YL, Li L, Pan QJ. Endocervical curretage: an analysis of results in 1997 women. Zhonghua Zhong Liu Za Zhi. 2004 Jul;26(7):406-8 (Article in Chinese).
  18. Zhao FH, Ma JF, Yang XP, Xiang XE, Rong SD, Li L, Zhang WH, Qiao YL, Association between high-risk human papillomavirus DNA load and Cervical intraepithelial lesion. Chin J Epidemiol., October 2004; 25(11):921-924 (Article in Chinese)
  19. Pretorius RG, Belinson JL, Qiao YL, Zhang WH, Li L, Wu LY. “Colposcopically Directed Biopsy, Random Cervical Biopsy, and Endocervical Curettage in the Diagnosis of Cervical Intraepithelial Neoplasia II or worse.” Am. J. OB/GYN, 2004 Aug; 191(2):430-4.
  20. Escobar PF, Rojas-Espaillat L, Belinson JL.  Optical Diagnosis of Cervical Dysplasia.   International Journal of Gynaecology & Obstetrics.  89(1):63-4, April 2005.
  21. Chen F, Shen Y-, Liu B, Pan QJ, Huang MN, Rong SD, Qiao YL. Studies on the detection of human papillomavirus in cervix cancer with hybrid capture II method. Chinese Journal of Medicine. 2005 Jan 12;85(2):129-30. (Article in Chinese).
  22. Zhao FH, Forman MR, Belinson JL, Shen YH, Graubard BI, Patel AC, Rong SD, Pretorius RG, Qiao YL.  Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China.  Int J Cancer. 2006 Jan 15; 118(2):  442-8.
  23. Pretorius RG, Zhang X, Belinson JL, Zhang WH, Ren SD, Bao YP, Qiao YL.  Distribution of cervical intraepithelial neoplasia 2, 3 and cancer of the uterine cervix.  J Low Genit Tract Dis. 2006 Jan; 10(1):  45-50.
  24. Pretorius RG, Kim RJ, Belinson JL, Elson P, Qiao YL.  Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy.  J Low Genit Tract Dis. 2006 Jan; 10(1):  5-9.
  25. Belinson JL.  Are screen-and-treat approaches effective for cervical cancer prevention?  Nat Clin Pract Oncol. 2006 Jun:3(6): 296-7.
  26. Belinson JL.  A randomized trial examining two alternative approaches to cervical cancer screening in low-resource setting (Khayelitsha, South Africa).  Oncology Abstracts Editorial Reviews.  Fall 2006.
  27. Belinson JL.  Screening for cervical cancer in underserved populations.  Abstracts in Hematology & Oncology Editorial Review.  Spring 2006, Vol 9, No. 2.
  28. Escobar PF, Rojas-Espaillat L, Tisci S, Enerson C, Brainard J, Smith J, Tresser NJ, Feldchtein FI, Rojas LB, Belinson JL.  Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix.  Int J Gynecol Cancer.  2006 Sept-Oct; 16(5):  1815-22.
  29. Zhao C, Li J, Tu Z, Song D, Cui SH, Zhang WH, Qiao YL, Wang JL, Belinson JL, Wei LH.  Study on the correlation between human papillomavirus infection and cervical lesion among women living in community of Beijing.  Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Oct; 28 (10): 947-50.  Chinese
  30. Pretorius RG, Belinson JL.  Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer. 2007 Nov 15; 121(10):  2218-24.
  31. Pretorius RG, Belinson JL.  Letter to the editor concerning Petignat et al.’s  “Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing?  A systemic review and meta-analysis.”  Gynecol Oncol 2007; 105(2):  530-535.
  32. Li XL, Wang H, Li CQ, Wu YP, Liu JH, Song D, Liu XF, Qiao YL. [Human papillomaviruses infections among village women in Henan province] Chinese Journal of Preventive Medicine. 2007 Jun;41 Suppl:77-80. Chinese.
  33. Li LY, Qiao ZQ, Zhang MF, Yang JP, Bao YP, An YT, Lei J, Xiong NH, Yu XH, Zhang X, Pan QJ, Qiao YL. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China] Chinese Journal of Epidemiology. 2007 Oct;28(10):964-7. Chinese.
  34. Bao YP, Li N, Wang H, Qiao YL*. [Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis] Chinese Journal of Epidemiology. 2007 Oct;28(10):941-6. Chinese.
  35. Yang B, MD, Pretorius RG, Belinson JL, Zhang X, Burchette R, Qiao YL. False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3.  Gynecol Oncol. 2008 May 15.
  36. Belinson S, Smith JS, Myers E, Olshan A, Belinson JL, Pretorius R, Qiao Y, Hartmann, K.  Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique.  Cancer Epidemiol Biomarkers Prev 2008; 17(9), Sept 2008
  37. Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, Xu AD, Wang JB, Liang H, Belinson JL, Qiao YL.  Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.  Vaccine. 2009 Feb 18;27 (8): 1210-5.  Epub 2009 Jan. 9.
  38. Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, Schmidt JE, Wang P, Liu YL, Li LK, Shi H, Liu JH, Xie X, Niyazi M, Yang P, Wei LH, Li LY, Li J, Liu JF, Zhou Q, Hong Y, Li L, Li Q, Zhou HL, Bian ML, Chen J, Qiao YL*, Smith JS.  Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control. 2009 20(9):1705-13.
  39. Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL*. Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia. Chinese Journal of Preventive Medicine. 2009 Jul;43(7):565-70. Chinese.
  40. Belinson, JL, Pretorius RG, Enerson C, Garcia F, Perez Cruz E, Belinson S, Yeverino Garcia E, Brainard J.  The Mexican Cervical Cancer Screening Trial (MECCS): Self-Sampling for the Human Papillomavirus with Unaided Visual Inspection as a Secondary Screen.  Int J Gyn Cancer.  2009 Jan; 19(1):27-32.
  41. Shi JF, Belinson JL, Zhao FH, Pretorius RG, Li J, Ma JF, Chen F, Xiang W, Pan QJ, Zhang X, Zhang WH, Qiao YL, Smith JS.  Human papillomavirus testing for cervical cancer screening:  results from a 6-year prospective study in rural China.  Am J Epidemiol. 2009 Sep 15; 170(6):708-16.
  42. Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith J, Li J, Taddeo F, Burchette R, Qiao YL.  Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal, and vaginal self-collected specimens; implications for vaginal self-collection.  Int J Gyn Cancer 2010 Sept 1; 127(5): 1151-7.
  43. Cagle A, Hu S, Sellors J, Bao Y, Lim J, Li S, Lewis K, Song Y, Ma J, Pan Q, Zhang W, Zhao F,
    Qiao Y*. Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acid (VIA). Int J Cancer. 2010  Jan 1. 126(1):156-61.
  44. Liu Z, Belinson SE, Li J, Yang B, Wulan N, Tresser NJ, Wang C, Mohr M, Zhang L, Zhou Y, Weng L, Wu RF, Belinson JL. Study of the diagnostic efficacy of “real time” optical coherence tomography (OCT) in the management of pre-invasive neoplasia of the uterine cervix. Int J Gynecol Cancer. 2010 Feb;20(2):283-7.
  45. Wulan N, Rasool N, Belinson SE, Wang C ,Rong X, Zhang W, Zhu YS, Yang B, Tresser NJ,  Mohr M, Wu RF, Belinson JL, . Study of the diagnostic efficacy of “real time” optical coherence tomography (OCT) as an adjunct to unaided visual inspection with acetic acid (VIA) for the diagnosis of pre-invasive and invasive neoplasia of the uterine cervix.  Int J Gynecol Cancer. 2010 Apr;20(3):422-7
  46. Belinson SE, Na W, Ruizhen L, Wei Z, Xuan R, Yasha Z, Wu R, Belinson JL. SNIPER: A novel assay for Human Papillomavirus testing among women in Guizhou, China.  Int J Gynecol Cancer. 2010 Aug;20(6):1006-10
  47. Arriba LN, Enerson CL, Belinson S, Novick L, Belinson J Int J Gynecol Cancer. Mexican Cervical Cancer Screening Study II: acceptability of human papillomavirus self-sampler 2010 Nov;20(8):1415-23.
  48. Ruifang W, Belinson SE, Hui D,Na W, Xinfeng Q, Ruosong W, Ying L, Chun W, Yanqiu Z, Lijie Z, Belinson JL. Human papillomavirus (HPV) mRNA assay for cervical cancer screening:  The Shenzhen Cervical Cancer Screening Trial I (SHENCCAST I). Int J Gynecol Cancer. 2010 Nov;20(8):1411-4
  49. Belinson SE, Belinson JL. Human Papillomavirus DNA Testing for Cervical Cancer Screening: Practical Aspects in Developing Countries. Molecular Diagnosis and Therapy. 2010:14(4), 215-222
  50. Zhao, FH, Lin, MJ, Chen F, Hu Sy, Zhang, R, Belinson JL, Sellors, JW, Franceschi, S, Qiao, YL, Castle, PE. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 populations-based studies from China.  Lancet Oncol. 2011 Jan;12(1):11.
  51. Kang W. Qi X. Tresser NJ. Kareta M. Belinson JL. Rollins AM. Diagnostic efficacy of computer extracted image features in optical coherence tomography of the precancerous cervix. Medical Physics. 38(1):107-13, 2011 Jan.
  52. GravittPE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for HPV testing of self-sampled vaginal specimens 1 as a cervical cancer screening strategy.  Int. J. Cancer: 129, 517–527 (2011).
  53. Pretorius RG, Belinson JL, Burchette RJ, Hu S, Zhang X, Qiao YL. Regardless of Skill, Performing More Biopsies Increases the Sensitivity of Colposcopy. J Low Genit Tract Dis. 2011  Jul;15(3):180-8.
  54. Belinson JL, Wu R, Belinson SE, Qu X, Yang B, Du H, Wu R, Wang C, Zhang L, Zhou Y, Liu Y, Pretorius RG.  A Population Based Clinical Trial Comparing Endocervical High-Risk HPV Testing using Hybrid Capture II and Cervista from the SHENCCAST II Study. Am J. Clinical Pathology 2011 May; 135(5):790-5. 
  55. Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, Pretorius RG, Yi X, Castle P. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing.  Int J Cancer. 2012 Apr 15;130(8):1855-60
  56. Du H, Yi J, Wu R, Belinson SE, Qu X, Yang B, Wang C, Yi X, Belinson JL.  A New PCR based Mass Spectrometry System for High-Risk HPV Part II – Clinical Trial. Am J Clin Pathol. 2011 Dec;136(6):920-3
  57. Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH, Pan QJ, Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL, Franceschi S. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012 Dec 15;131(12):2929-38
  58. Smith JS, Lewkowitz AK, Qiao YL, Ji J, Md SH, Chen W, Md RZ, Liaw KL, Esser M, Taddeo FJ, Pretorius RG, Belinson JL.Population-based human papillomavirus 16,18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer. 2012 Sep 15;131(6):1388-95. 
  59. Shi JF, Chen JF, Canfell K, Feng XX, Ma JF, Zhang YZ, Zhao FH, Li R, Ma L, Li ZF, Lew JB, Ning Y,Qiao YL.  Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study.BMC Health Serv Res. 2012 May 24;12:123. 
  60. Belinson SE, Ledford K, Rasool N, Rollins A, Wilan N, Wang C, Rong X, Zhang W, Zhu Y, Tresser N, Wu R, Belinson JL. Cervical Epithelial Brightness by Optical Coherence Tomography Can Determine Histological Grades of Cervical Neoplasia. J Low Genit Tract Dis. 2013 Apr;17(2):160-6
  61. Belinson JL, Pretorius RG. Vaginal Self-Collection in Human Papillomavirus Testing. US Obstetrics and Gynecology (Touch Briefings) 2011; 6(2), 13-15 and Eur Obstetrics and Gynaecology (Touch Briefings) 2012; 7(1), 42-44.
  62. Wu R, Du H, Belinson SE, Pretorius RG, Zou J, Yang B, Wang C, Belinson JL. Secondary screening after primary self-sampling for human papillomavirus from SHENCCAST II. J Low Genit Tract Dis. 2012 Oct;16(4):416-20. 
  63. Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, Pretorius RG, Chen W, Belinson JL, Qiao YL. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women. Infect Dis. 2012 Jun 20;12:137. 
  64. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012 Feb 8;104(3):178-88.
  65. Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J. The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy. Int J Cancer. 2013 Jan 1;132(1):101-8. 
  66. Pretorius RG, Belinson JL, Azizi F, Peterson PC, Belinson S. Utility of random cervical biopsy and endocervical curettage in a low-risk population. J Low Genit Tract Dis. 2012 Oct;16(4):333-8. 
  67. Nieves L, Enerson CL, Belinson S, Brainard J, Chiesa-Vottero A, Nagore N, Booth C, Pérez AG, Chávez-Avilés MN, Belinson J. Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection. Int J Gynecol Cancer. 2013 Mar; 23(3):513-8
  68. Levinson KL, Abuelo C, Chyung E, Salmeron J, Belinson SE, Sologuren CV, Ortiz CS, Vallejos MJ, Belinson JL. The Peru Cervical Cancer Prevention Study (PERCAPS): Community-Based Participatory Research in Manchay, Peru. Int J Gynecol Cancer. 2013 Jan;23(1):141-147.
  69. Abuelo CE,  Levinson KL, Salmeron J, Belinson SE, Sologuren CV, Fernandez MJ, Belinson, JL. The Peru Cervical Cancer Screening Study (PERCAPS):The design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian Jungle. J  Community Health 2013 Nov 26 [Epub ahead of print]
  70. Levinson KL, Abuelo C, Chyung E, Salmeron J, Belinson SE,  Sologuren CV, Ortiz CS, Vallejos MJ, Belinson JL. The Peru Cervical Cancer Prevention Study (PERCAPS): The Technology to Make Screening Accessible. Gynecol Oncol. 2013 May;129(2):318-23
  71. Wang SM, Colombara D, Shi JF, Zhao FH,  Li J, Chen F, Chen W, Li SM, Zhang X, Pan QJ, Belinson JL, Smith JS, and Qiao YL. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses. Int J Gynecol Cancer. 2013 May;23(4):716-23.
  72. CastlePE, de Sanjosé S, Qiao YL, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012 Nov 20;30 Suppl 5:F117-22. 
  73. Pretorius RG, Belinson JL. Colposcopy. Minerva Ginecol. 2012 Apr;64(2):173-80. Review.
  74. Starks D, Nieves L, Enerson CL, Brainard J,  Nagore N, Belinson SE,  Andres Chiesa A, Uribe J, MD, and Belinson JL. MexicanCervical Cancer Screening Study II (MECCS II): 6 month and 2 year follow up.  Accepted October, 2013 to Journal of Lower Genital Tract Disease.
  75. Goodrich SK,  Schlegel CR, Belinson JL  A review on the use of Artemisinin to treat HPV infected cells and cervical cancer. Accepted 2013 by Future Medicine.
  76. Yi X, Zou J, Xu J, Liu T, Liu T,  Hua S, Xi F, Nie X,  Xu L, Du D, Wu R, Yang L, Wang J, Belinson JL. Development and validation of a new HPV genotyping assay based on next generation sequencing. Accepted November 2013, Am J. Clinical Pathology.
  77. Pan QJ, Hu SY, Zhang X, Ci PW, Zhang WH, Guo HQ, Cao J, Zhao FH, Lytwyn A, Qiao YL.  Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.Cancer Cytopathol. 2013 Sep;121(9):473-82. 
  78. Pretorius RG, Belinson JL, Peterson P, Azizi F, Lo A. Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high-risk human papillomavirus test results. J Low Genit Tract Dis. 2013 Oct;17(4):430-9. 
  79. Goodrich SK, Pretorius RG, Du H, Wu R, Belinson JL. Triage of Women With Negative Cytology and Positive High-Risk HPV: An Analysis of Data From the SHENCCAST II/III Studies. J Low Genit Tract Dis. 2013 Nov 21. [Epub ahead of print] PubMed PMID: 24270196.
  80. Zhang R, Velicer C, Chen W, Liaw KL, Wu EQ, Liu B, Cui JF, Belinson JL, Zhang X, Shen GH, Chen F, Qiao YL. Human papillomavirus genotype distribution incervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study. Cancer Epidemiol. 2013 Dec;37(6):939-45. doi:10.1016/j.canep.2013.10.005. Epub 2013 Nov 8. PubMed PMID: 24210584.
  81. Liang LY, Du H, Wang C, Zhang W, Chen Y, Qu XF, Yang B, Wu B, Wu RS, Belinson JL, Wu RF. [Crosssectional survey of human papilloma virus subtype distribution and cervical intraepithelial neoplasia in Shenzhen]. Beijing Da Xue Xue Bao. 2013 Feb 18;45(1):114-8. Chinese. PubMed PMID: 23411532.
  82. Sui S, Jiao Z, Niyazi M, S S, Lu P, Qiao YL.Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in uyghur women.Asian Pac J Cancer Prev. 2013;14(10):5861-5.
  83. Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, Niyazi M, Zhao C, Ren SD, Li CQ, Gong XZ, Smith JS, Belinson JL, Liaw KL, Velicer C, Qiao YL. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control. 2013 Apr;24(4):795-803. doi: 10.1007/s10552-013-0162-8. Epub 2013 Feb 9. 
  84. Wang H, Wang T, Hu SY, Zhao FH, Zhang X, Pan QJ, Zhang WH, Li L, Qiao YL. Comparison on the predictive values of four screening methods regarding cervical cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Feb;34(2):191-4. Chinese.
  85. Belinson JL, Wang GX, Qu XF, Du H, Shen JJ, Xu JJ, Zhong LQ, Yi J, Yi X, Wu RF.The Development and Evaluation of a Community Based Model for Cervical Cancer Screening Based on Self-sampling. Gynecol Oncol. 2014 Mar;132(3):636-42. doi: 10.1016/j.ygyno.2014.01.006. Epub 2014 Jan 14
  86. Boers A, Slagter-Menkema L, van Hemel BM, Belinson JL, Ruitenbeek T, Buikema HJ, Klip H, Ghyssaert H, van der Zee AG, de Bock GH, Wisman GB, Schuuring E. Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off. PLoS One. 2014 Jul 22;9(7):e101930. doi: 10.1371/journal.pone.0101930. eCollection 2014.
  87. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Which Colposcopies Should Include Endocervical Curettage? J Low Genit Tract Dis. 2015 Jun 16. [Epub ahead of print].
  88. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Factors That Virtually Exclude Cervical Cancer at Colposcopy. J Low Genit Tract Dis. 2015 Jun 16. [Epub ahead of print].
  89. Zhang L, Du H, Zhang W, Yang B, Wang C, Belinson JL, Wu R. Diagnostic value of multiply biopsies and endocervical curettage on cervical lesions. Zhonghua Fu Chan Ke Za Zhi. 2015 Apr;50(4):263-7. Chinese. 
  90. Krishnan S, Sivaram S, Anderson BO, Basu P, Belinson JL, Bhatla N, Cruz AD, Dhillon PK, Gupta PC, Joshi N, Jhulka PK, Kailash U, Kapambwe S, Katoch VM, Kaur P, Kaur T, Mathur P, Prakash A, Sankaranarayanan R, Selvam JM, Seth T, Shah KV, Shastri S, Siddiqi M, Srivastava A, Trimble E, Rajaraman P, Mehrotra R. Using implementation science to advance cancer prevention in India. Asian Pac J Cancer Prev. 2015;16(9):3639-44.
  91. Sewali B, Okuyemi KS, Askhir A, Belinson J, Vogel RI, Joseph A, Ghebre RG. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial. Cancer Med. 2015 Apr;4(4):620-31. doi: 10.1002/cam4.429. Epub 2015 Feb 4.
  92. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Factors That Virtually Exclude Cervical Cancer at Colposcopy. . J Low Genit Tract Dis. 2015 Jun 16. [Epub ahead of print]
  93. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Which Colposcopies Should Include Endocervical Curettage? 226. Lancet Oncol. 2015 Jul;16(7):e352-61. doi: 10.1016/S1470-2045(15)00078-9.
  94. Rajaraman P, Anderson BO, Basu P, Belinson JL, , Dhillon PK, Gupta P, Jawahar TS, Joshi N, Kailash U, Kapambwe S, Katoch VM, Krishnan S, Panda D, Sankaranarayanan R, Selvam JM, Shah KV, Shastri S, Shridhar K,  Siddiqi M, Sivaram S, Seth T, Srivastava A, Trimble E, Mehrotra R. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015 Jul;16(7):e352-61. doi: 10.1016/S1470-2045(15)00078-9. Review.
  95. Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, Wilkinson-Ryan I, Lawson PJ, Fader AN, Belinson JL. Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study. J Low Genit Tract Dis. 2016 Jan;20(1):47-51. doi: 10.1097/LGT.0000000000000153.
  96. Zhao J, Du H, Belinson JL, Qu X, Zhang W, Mei J, Yang B, Wang C, Zhang L, Wu R. Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer. J Med Screen. 2015 Oct 14. pii: 0969141315604863. [Epub ahead of print]
  97. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Which Colposcopies Should Include Endocervical Curettage? J Low Genit Tract Dis. 2015 Oct;19(4):278-81. doi: 10.1097/LGT.0000000000000119.
  98. Pretorius RG, Belinson JL, Peterson P, Burchette RJ. Factors That Virtually Exclude Cervical Cancer at Colposcopy. J Low Genit Tract Dis. 2015 Oct;19(4):319-22. doi: 10.1097/LGT.0000000000000122.
  99. Zhang L, Du H, Zhang W, Yang B, Wang C, Belinson JL, Wu R. Diagnostic value of multiply biopsies and endocervical curettage on cervical lesions. Zhonghua Fu Chan Ke Za Zhi. 2015 Apr;50(4):263-7. Chinese. 
  100. Qing Chen, MD; Hui Du, MD; Robert G. Pretorius, MD; Chun Wang, MD; Bin Yang, MD, PhD; Guixiang Wang, MD; Jinlong Tang, MD; Jerome L. Belinson, MD; Ruifang Wu, MD. High-grade CIN detected by colposcopic directed or random biopsy relative to age, cytology, HPV 16, and lesion size. J Low Genit Tract Dis. 2016 Jul;20(3):207-12. doi: 10.1097
  101.   Cynthia Arvizo, MD; Qing Chen, MD; Hui Du, MD; Chun Wang, MD; Jinlong Tang, MD; Bin Yang, MD, PhD; Robert G. Pretorius, MD; Ruifang Wu, MD; Jerome L. Belinson, MD. p16 immunohistochemistry in colposcopic-directed and random cervical biopsies of CIN2 and CIN3. J Low Genit Tract Dis. 2016 Feb 5. [Epub ahead of print]
  102. Kathryn Maurer MD, Hongxue Luo MD, Zhiyong Shen PhD, Guixiang Wang MD, Hui Du MD, Chun Wang MD, Xiaobo Liu MS, Zhihong Liu, Lijie Zhang, Yanqiu Zou, Xinfeng Qu MD, Ruifang Wu MD, and Jerome Belinson MD. The Development and Evaluation of a New Solid Media Specimen Transport Card for Population Based Cervical Cancer Prevention. J Clin Virol. 2016 Mar;76:14-9. doi: 10.1016/j.jcv.2015.12.010. Epub 2016 Jan 2.
  103. Hongxue Luo, Hui Du, Kathryn Maurer, Jerome L. Belinson, Guixiang Wang, Zhihong Liu, Lijie Zhang, Yanqiu Zhou, Chun Wang, Jinlong Tang, Xinfeng Qu, Ruifang Wu. An evaluation of the Cobas4800 HPV test on cervico-vaginal specimens in liquid versus solid transport media. PLoS One. 2016 Feb 1;11(2):e0148168. doi: 10.1371/journal.pone.0148168. eCollection 2016.
  104. Mahirah Ma’som; Nirmala Bhoo Pathy; Nazrila Hairizan Nasir; Jerome Belinson; ShriDevi Subramaniam; Linda Ma; Patti Gravitt; Goh Pik Pin; Woo Yin Ling. Attitudes and factors affecting acceptability of self-administered cervico-vaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multi-ethnic Malaysian women. Accepted July 2016, BMJ Open Access.
  105. Chong Liu, MD; Hui Du, MD; Chun Wang, MD; Jerome L. Belinson, MD; Bin Yang, MD; Wei Zhang, MD; Jinlong Tang, MD; Ruifang Wu, MD. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2+. Accepted July 2016 International Journal of Gynecologic Pathology.
  106. Jin XW, Lipold L, Foucher J, Sikon A, Brainard J, Belinson J, Schramm S, Nottingham K, Hu B, Rothberg MB. Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years. J Gen Intern Med. 2016 Jul 14.
  107. Belinson JL, Pretorius RG. A Standard Protocol for the Colposcopy Exam. J Low Genit Tract Dis. 2016 Oct;20(4):e61-2. doi: 10.1097J. 
  108. M. Arbyn, L. Xu, F. Verdoodt, J. Cuzick, A. Szarewski, J.L. Belinson, Wentzensen, J.C. Gage, M.J. Khan. Genotyping for HPV16 and HPV18 in women with minor cytologic abnormalities: a systematic review and meta-analysis. Ann Intern Med. 2017 Jan 17;166(2):118-127. doi: 10.7326/M15-2735. Epub 2016 Nov 15
  109. Pretorius RG1, Belinson JL. When Should Endocervical Curettage Be Done? J Low Genit Tract Dis. 2016 Apr;20(2):189. doi: 10.1097/LGT.0000000000000180. 
  110. Hongxue Luo, MD; Jerome L. Belinson, MD; Hui Du, MD; Zhihong Liu, MD; Lijie Zhang, MD; Chun Wang, MD; Xinfeng Qu, MD; Robert G. Pretorius, MD; Ruifang Wu, MD.  Evaluation of Viral Load as a Triage Strategy with Primary High-risk HPV Cervical Cancer Screening. J Low Genit Tract Dis. 2017 Jan;21(1):12-16. doi: 10.1097/LGT.0000000000000277.
  111. Su Pei Khoo , Nirmala Bhoo-Pathy , Siew Hwei Yap , Mohd Khairul Anwar Shafii,  Nazrila Hairizan Nasir, Jerome Belinson , ShriDevi Subramaniam, Pik Pin Goh, Ming Zeng, Hong Dong Tan,  Patti Gravitt, Yin Ling Woo. The prevalence and socio-demographic correlates of cervico-vaginal human papillomavirus (HPV) carriage in a cross sectional multi-ethnic community-based female Asian population. Sex Transm Infect. 2017 Nov 27. pii: sextrans-2017-053320. doi: 10.1136/sextrans-2017-053320. 
  112. Smith JS, Des Marais AC, Deal AM, Richman AR, Perez-Heydrich C, Yen-Lieberman B, Barclay L, Belinson J, Rinas A, Brewer NT. Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States. Sex Transm Dis. 2017 Jul 26. doi: 10.1097/OLQ.0000000000000681
  113. Wu S, Sun J, Lv H, Zhang Y2, Shang H, Zhang H, Belinson JL Pregnancy in a woman with untreated bladder exstrophy: a case report. Case Rep. Womens Health. 2018 Mar 10;17:11-13. doi: 10.1016/j.crwh.2018.02.002. eCollection 2018 Jan; 17:11-13.
  114. Belinson JL, Pretorius RG, Qu X. Letter to the editor: Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities.Obstet.Gynecol.2019:Mar;133(3):583.doi:10.1097/AOG.0000000000003147
  115. Hongxue Luo, Hui Du, Jerome L. Belinson, Ruifang Wu. Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms. PLoS One. 2019; 14(7): e0220200. Published online 2019 Jul 26. doi: 10.1371/journal.pone.0220200 PMCID: PMC6660090
  116. Robert G Pretorius, Jerome L Belinson, Raoul J Burchette, Ruifang Wu, You-Lin Qiao. Key Determinants of the Value of Random Cervical Biopsy at Colposcopy. J Low Genit Tract Dis. 2019 Oct;23(4):241-247. doi: 10.1097/LGT.0000000000000485
  117. Wei Zhang, Hui Du, Xia Huang, Chun Wang, Xianzhi Duan, Yan Liu, Bin Shi, Wei Zhang, Xinfeng Qu, Lihui Wei, M. Schiffman, J. L. Belinson, Ruifang Wu. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening. Infect Agent Cancer. 2020; 15: 65. Published online 2020 Oct 23. doi: 10.1186/s13027-020-00328-1 PMCID: PMC7583687.
  118. Kayode Olusegun Ajenifuja, Jerome Belinson, Andrew Goldstein, Kanan T. Desai, Silvia de Sanjose, Mark Schiffman. Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self sampled HPV typing. Infect Agent Cancer. 2020; 15: 61. Published online 2020 Oct 14. doi: 10.1186/s13027-020-00325-4 PMCID: PMC7556607
  119. Fangbin Song, Hui Du, Aimin Xiao, Chun Wang, Xia Huang, Peisha Yan, Zhihong Liu, Xinfeng Qu, Jerome L. Belinson, Ruifang Wu. Evaluating the Performance of p16 Immunocytochemistry in Cervical Cancer Screening. Cancer Manag Res. 2020; 12: 9067–9075. Published online 2020 Sep 25. doi: 10.2147/CMAR.S273079 PMCID: PMC7524171.
  120. Lyufang Duan, Hui Du, Chun Wang, Xia Huang, Xinfeng Qu, Bin Shi, Yan Liu, Wei Zhang, Xianzhi Duan, Lihui Wei, Jerome L. Belinson, Ruifang Wu. The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples. PLoS One. 2020; 15(5): e0232107. Published online 2020 May 7. doi: 10.1371/journal.pone.0232107 PMCID: PMC7205204.
  121. Jingfen Sun MD, Suhui Wu MD PhD, Longhua Hu MD, Haixia Shang MD, PhD, Yufeng Yang BS, Robert Pretorius MD, Yaling Huang BS, Xi Yang, MD, MS, Xiaoqin Wu BS, Jerome Belinson MD.  Evaluation of liquid vs. dry specimen transport with a newly validated isothermal amplification HR-HPV Assay. J Low Gent Tract Dis 2020;24:243-246.
  122. Jerome L. Belinson MD, Robert G. Pretorius MD, Ruifang Wu, MD. The Ampfire HPV Technology. HPV World. www.HPVworld.com. 2020; no. 119.
  123. Philip E Castle, Amanda J Pierz, Rachael Adcock, Shagufta Aslam, Partha S Basu, Jerome L Belinson, Jack Cuzick, Mariam El-Zein, Catterina Ferreccio, Cynthia Firnhaber, Eduardo L Franco, Patti E Gravitt, Sandra D Isidean, John Lin, Salaheddin M Mahmud , Joseph Monsonego, Richard Muwonge, Samuel Ratnam, Mahboobeh Safaeian, Mark Schiffman, Jennifer S Smith, Avril Swarts, Thomas C Wright, Vanessa Van De Wyngard , Long Fu Xi.  A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer Prev Res. 2020 Oct;13(10):829-840. doi: 10.1158/1940-6207.CAPR-20-0182. Epub 2020 Jul 12.
  124. Fangbin Song, Hui Du, Chun Wang, Xia Huang, Xinfeng Qu, Lihui Wei, Jerome L Belinson, Ruifang Wu, CHIMUST team. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.  J. Med. Screening. 2021. Sept. 28(3):318-324. https://doi.org/10.1177/0969141320943634
  125. Duan L, Du H, Belinson JL, Liu Z, Xiao A, Liu S, Zhao L, Wang C, Qu X, Wu R. Thermocoagulation versus cryotherapy for the treatment of cervical precancers. J Obstet Gynaecol Res. 2021 Jan;47(1):279-286. doi: 10.1111/jog.14520. Epub 2020 Oct 21.
  126. Robert G Pretorius, Jerome L Belinson, Patricia Peterson. Loop Electrosurgical Excision Procedure or Cervical Conization to Exclude Cervical Cancer Before Simple Hysterectomy. J Low Genit Tract Dis. . 2020 Apr;24(2):202-205. doi: 10.1097/LGT.0000000000000519.
  127. Du, Hui; Duan, Xianzhi; Liu, Yan; Shi, Bin; Zhang, Wei; Wang, Chun; Qu, Xinfen; Bao, Juncui; Li, Jingran; Zhao, Chao; Jiang, Jing; Liu, Juan; Wu, Kejia; Xiao, Aimin; Duan, Lvfang; Huang, Xia; Bian, Shuhuang; Zhang, Lijie; Luo, Hongxue; Wei, Lihui; Belinson, Jerome L.; Wu, Ruifang. An evaluation of solid versus liquid transport media for high-risk HPV detection and cervical cancer screening on self-collected specimens Infectious Agents and Cancer, 2020, 15(1): 72.
  128. Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson Jerome L, Wu RF. Zhonghua Fu Chan Ke Za Zhi. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening]. 2020 Nov 25;55(11):784-790.
  129. Pretorius RG, Belinson JL. Re: An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. J Natl Cancer Inst. 2020 Jan 1;112(1):114.
  130. Du H, Duan X, Liu Y, Shi B, Zhang W, Wang C, Qu X, Li J, Zhao C, Liu J, Jiang J, Jin H, Li H, Xiao A, Bao J, Duan L, Huang X, Luo H, Bian S, Zhang L, Wei L, Belinson JL, Wu R. Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening Trial. J Low Genit Tract Dis. 2021 Jan 1;25(1):22-26.
  131. Khoo SP, Shafii MKA, Bhoo-Pathy N, Yap SH, Subramaniam S, Nasir NH, Lin Z, Belinson J, Goh PP, Qu X, Gravitt P, Woo YL. Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population. PLoS One. 2021 Jan 20;16(1)
  132. Guo C, Du H, Belinson JL, Wang C, Huang X, Qu X, Wu R; CHIMUST team. Infect Agent Cancer. The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women. 2021 Mar 25;16(1):21.
  133. Pretorius RG, Belinson JL. Comments on: Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution micro-endoscopy to detect cervical precancer. Int J Cancer. 2021 Apr 4.
  134. Du H, Luo H, Wang C, Qu X, Belinson JL, Wu R. The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features. J Clin Epidemiol. 2021 Jun 20: S0895-4356(21)00187-6.
  135. Song F, Belinson JL, Yan P, Huang X, Wang C, Du H, Qu X, Wu R. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China. Gynecol Oncol. 2021 Aug;162(2):322-330.
  136. Guo CL, Luo HX, Wang C, Qu XF, Yang B, Belinson JL, Du H, Wu RF. Zhonghua Fu Chan Ke Za Zhi. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening]. 2021 Apr 25;56(4):271-279. doi: 10.3760/cma.j.cn112141-20200824-00357.
  137. LonghuaHu, SuhuiWu, HaixiaShang, JeromeBelinson, JinhongLi, XiaoqinWu, YalingHuang, JingfenSun.Evaluation of dry specimen transport and processing time using an isothermal amplification high-risk human papillomavirus assay. Obstet. Gynecol. Clinical Medicine. https://doi.org/10.1016/j.gocm.2022.01.009
  138. Qing Yang, Hui Du, Xinfeng Qu, Wenkui Dai, Liming Gui, Changzhong Li, Chun Wang, Chunlei Guo, Yi Zhang, Lihui Wei, J. L. Belinson and Ruifang Wu. Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening.  Front. Public Health, Sec. Infectious Diseases: Epidemiology and Prevention; 10 November 2022. https://doi.org/10.3389/fpubh.2022.1010066
  139. Chunlei Guo, Hui Du, Xinfeng Qu, Xianzhi Duan, Jingran Li, Ruizhen Li, Hua Jin, Chun Wang, Chao Zhao, Juncui Bao, Hongxue Luo, Lihui Wei, J L Belinson, Ruifang Wu. Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST. Front. Public Health. 2022 May 25;1

  140. Preventive Oncology International: A brief history of HPV self-collected vaginal specimens for cervical cancer screening. doi: 10.3389/fpubh.2022.840879. eCollection 2022.